Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS: OTLC · Delayed Price · USD
0.0310
-0.0020 (-6.06%)
Jul 1, 2024, 3:55 PM EDT - Market closed

Oncotelic Therapeutics Market Cap

Oncotelic Therapeutics has a market cap or net worth of $12.39 million as of July 2, 2024. Its market cap has decreased by -53.42% in one year.

Market Cap
12.39M
Enterprise Value
25.50M
1-Year Change
-53.42%
Ranking
n/a
Category
Stock Price
$0.03

Market Cap Chart

Since December 1, 1998, Oncotelic Therapeutics's market cap has decreased from $87.40M to $12.39M, a decrease of -85.82%. That is a compound annual growth rate of -7.53%.

History

DateMarket Cap% Change
Nov 14, 202313.20M-25.00%
Dec 30, 202217.60M-71.88%
Dec 31, 202162.60M224.35%
Dec 31, 202019.30M36.88%
Dec 31, 201914.10M487.50%
Dec 31, 20182.40M-40.00%
Dec 29, 20174.00M-58.33%
Dec 30, 20169.60M-52.48%
Dec 31, 201520.20M-39.34%
Dec 31, 201433.30M321.52%
Dec 31, 20137.90M-14.13%
Dec 31, 20129.20M-37.41%
Dec 30, 201114.70M-40.73%
Dec 31, 201024.80M-65.17%
Dec 31, 200971.20M208.23%
Dec 31, 200823.10M-67.46%
Dec 31, 200771.00M-47.52%
Dec 29, 2006135.30M65.81%
Dec 30, 200581.60M-11.30%
Dec 31, 200492.00M-20.62%
Dec 31, 2003115.90M771.43%
Dec 31, 200213.30M-62.11%
Dec 31, 200135.10M-47.46%
Dec 29, 200066.80M-58.35%
Dec 31, 1999160.40M46.22%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 860.48B
Novo Nordisk 629.27B
UnitedHealth Group 468.72B
Johnson & Johnson 351.76B
Merck & Co. 313.56B
AbbVie 302.88B
AstraZeneca 241.81B
Thermo Fisher 211.09B
Market Cap Rankings